ArticleCommunications medicine2024

Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial.

Philip Sasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.